Latest stories on HRTX
Heron Therapeutics Appeals Ruling Invalidating CINVANTI Patents
TipRanks33 · bearishgeneral
U.S. District Court Issues Decision Regarding CINVANTI® Patents | HRTX Stock News
StockTitan58 · neutralgeneral
Why Heron Therapeutics, Inc. (HRTX) Price Target Was Reduced to $4 at H.C. Wainwright?
Yahoo Finance38 · neutralanalyst
Heron Therapeutics, Inc. Q1 2026 Earnings Call Summary
Yahoo Top58 · neutralearnings
Heron Therapeutics Q1 Earnings Call Highlights
Yahoo Top53 · neutralearnings
Acute Care Revenue Growth Helps Heron (HRTX) Reaffirm 2026 Guidance Despite Q1 Sales Decline
Yahoo Finance58 · neutralearnings